Literature DB >> 21188769

Prostate cancer: Risk stratification of PSA-based screening.

Suzanne J Farley.   

Abstract

Entities:  

Year:  2010        PMID： 21188769     DOI： 10.1038/nrurol.2010.192

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  3 in total

1.  The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.

Authors:  Andrew J Vickers; Angel M Cronin; Monique J Roobol; Jonas Hugosson; J Stephen Jones; Michael W Kattan; Eric Klein; Freddie Hamdy; David Neal; Jenny Donovan; Dipen J Parekh; Donna Ankerst; George Bartsch; Helmut Klocker; Wolfgang Horninger; Amine Benchikh; Gilles Salama; Arnauld Villers; Steve J Freedland; Daniel M Moreira; Fritz H Schröder; Hans Lilja
Journal:  Clin Cancer Res       Date:  2010-08-24       Impact factor: 12.531

2.  Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.

Authors:  Hans Lilja; Angel M Cronin; Anders Dahlin; Jonas Manjer; Peter M Nilsson; James A Eastham; Anders S Bjartell; Peter T Scardino; David Ulmert; Andrew J Vickers
Journal:  Cancer       Date:  2010-10-19       Impact factor: 6.860

3.  Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Authors:  Andrew J Vickers; Angel M Cronin; Thomas Björk; Jonas Manjer; Peter M Nilsson; Anders Dahlin; Anders Bjartell; Peter T Scardino; David Ulmert; Hans Lilja
Journal:  BMJ       Date:  2010-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.